Top

Published in:

01-06-2012

Is Serum S100B Protein a Biomarker for Amitriptyline-Induced Cardiovascular Toxic Effects?

Authors: Nil Hocaoglu, Sule Kalkan, Mujgan Buyukdeligoz, Kubilay Oransay, Yesim Tuncok

Published in: Cardiovascular Toxicology | Issue 2/2012

Abstract

The aim of this study was to assess the role of serum S100B protein as a biomarker for cardiovascular effects in an anesthetized rat model of amitriptyline toxicity. Adult male Wistar rats (n = 28) were randomized into four groups. While the control group received normal saline, the experimental groups received different doses of amitriptyline (0.625 or 0.94 or 1.25 mg/kg/min) infusion. Mean arterial pressure (MAP), heart rate (HR), electrocardiogram parameters, and serum S100B protein levels were recorded during the experiment. Linear Pearson’s correlation coefficient was used to examine the association between cardiovascular parameters and serum levels of S100B protein. In the experimental groups, amitriptyline caused a significant decrease in MAP and HR (P < 0.001), a prolongation in QRS duration and QT intervals (P < 0.01), but it did not change PR intervals significantly. At the end of the experiment of the second group, a significant correlation was found between HR and serum S100B protein levels (r = −0.963, P = 0.037). At the end of the experiment of the third and fourth groups, a significant correlation between MAP, HR, all ECG parameters, and serum S100B protein levels was found. Serum S100B protein levels correlate well with amitriptyline-induced cardiovascular toxicity and can be used as a biomarker for predicting cardiovascular toxic effects of amitriptyline.

Benowitz, N. L. (2004). Tricyclic antidepressants. In K. R. Olson (Ed.), Poisoning and drug overdose (pp. 310–312). New York: McGraw-Hill.

Olgun, H., Yildirim, Z. K., Karacan, M., & Ceviz, N. (2009). Clinical, electrocardiographic, and laboratory findings in children with amitriptyline intoxication. Pediatric Emergency Care, 25, 170–173.PubMedCrossRef

Gürsoy, M., & Büyükuysal, R. L. (2010). Mechanism of S100b release from rat cortical slices determined under basal and stimulated conditions. Neurochemical Research, 35, 429–436.PubMedCrossRef

Donato, R. (2001). S100: A multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. International Journal of Biochemistry and Cell Biology, 33, 637–668.PubMedCrossRef

Kahn, H. J., Baumal, R., Van Eldik, L. J., Dunn, R. J. and Marks, A. (1991). Immunoreactivity of S100 beta in heart, skeletal muscle, and kidney in chronic lung disease: possible induction by cAMP. Modern Pathology 4, 698–701 (abstract).

Tsoporis, J. N., Marks, A., Kahn, H. J., Butany, J. W., Liu, P. P., O’Hanlon, D., et al. (1998). Inhibition of norepinephrine induced cardiac hypertrophy in S100beta transgenic mice. Journal of Clinical Investigation, 102, 1609–1616.PubMedCrossRef

Mazzini, G. S., Schaf, D. V., Oliveira, A. R., Gonçalves, C. A., Belló-Klein, A., Bordignon, S., et al. (2005). The ischemic rat heart releases S100B. Life Sciences, 77, 882–889.PubMedCrossRef

Banfalvi, T., Gergye, M., Beczassy, E., Gilde, K. and Otto, S. (2004). Role of S100B protein in neoplasms and other diseases. Magyar Onkologia. 48, 71–74 (abstract).

Akhisaroglu, M., Manev, R., Akhisaroglu, E., Uz, T., & Manev, H. (2003). Both aging and chronic fluoxetine increase S100B content in the mouse hippocampus. Neuroreport, 14, 1471–1473.PubMedCrossRef

10.

Manev, R., Uz, T., & Manev, H. (2001). Fluoxetine increases the content of neurotrophic protein S100b in the rat hippocampus. European Journal of Pharmacology, 420, 1–2.CrossRef

11.

Rothermundt, M., Arolt, V., Wiesmann, M., Missler, U., Peters, M., Rudolf, S., et al. (2001). S-100B is increased in melancholic but not in non-melancholic major depression. Journal of Affective Disorders, 66, 89–93.PubMedCrossRef

12.

Hachimi-Idrissi, S., Van der Auwera, M., Schiettecatte, J., Ebinger, G., Michotte, Y., & Huyghens, L. (2002). S-100 protein as early predictor of regaining consciousness after out of hospital cardiac arrest. Resuscitation, 53, 251–257.PubMedCrossRef

13.

Yardan, T., Cevik, Y., Donderici, O., Kavalci, C., Yilmaz, F. M., Yilmaz, G., et al. (2009). Elevated serum S100B protein and neuron-specific enolase levels in carbon monoxide poisoning. American Journal of Emergency Medicine, 27, 838–842.PubMedCrossRef

14.

Regner, A., Kaufman, M., Friedman, G., & Chemale, I. (2001). Increased serum S100beta protein concentrations following severe head injury in humans: A biochemical marker of brain death? Neuroreport, 12, 691–694.PubMedCrossRef

15.

Oertel, M., Schumacher, U., McArthur, D. L., Kästner, S., & Böker, D. K. (2006). S-100B and NSE: Markers of initial impact of subarachnoid haemorrhage and their relation to vasospasm and outcome. Journal of Clinical Neuroscience, 13, 834–840.PubMedCrossRef

16.

Kaplan, Y. C., Hocaoglu, N., Oransay, K., Kalkan, S., & Tuncok, Y. (2008). Effect of glucagon on amitriptyline-induced cardiovascular toxicity in rats. Human and Experimental Toxicology, 27, 321–325.PubMedCrossRef

17.

Oransay, K., Kalkan, S., Hocaoglu, N., Akgun Arici, A., & Tuncok, Y. (2011). An alternative antidote therapy in amitriptyline induced rat toxicity model–theophylline. Drug and Chemical Toxicology, 34, 53–60.PubMedCrossRef

18.

Kalkan, S., Aygoren, O., Akgun, A., Gidener, S., Guven, H., & Tuncok, Y. (2004). Do adenosine receptors play a role in amitriptyline-induced cardiovascular toxicity in rats. Journal of Toxicology Clinical Toxicology, 42, 945–954.PubMedCrossRef

19.

Spinella, P. C., Dominguez, T., Drott, H. R., Huh, J., McCormick, L., Rajendra, A., et al. (2003). S-100beta protein–serum levels in healthy children and its association with outcome in pediatric traumatic brain injury. Critical Care Medicine, 31, 939–945.PubMedCrossRef

20.

Foerch, C., de Rochemont, R., Singer, O., Neumann-Haefelin, T., Buchkremer, M., Zanella, F. E., et al. (2003). S100B as a surrogate marker for successful clot lysis in hyperacute middle cerebral artery occlusion. Journal of Neurology, Neurosurgery and Psychiatry, 74, 322–325.CrossRef

21.

Thanacoody, H. K., & Thomas, S. H. (2005). Tricyclic antidepressant poisoning: Cardiovascular toxicity. Toxicological reviews, 24, 205–214.PubMedCrossRef

22.

Buckley, N. A., Chevalier, S., Leditschke, I. A., O’Connell, D. L., Leitch, J., & Pond, S. M. (2003). The limited utility of electrocardiography variables used to predict arrhythmia in psychotropic drug overdose. Critical Care, 7, 101–107.CrossRef

Title: Is Serum S100B Protein a Biomarker for Amitriptyline-Induced Cardiovascular Toxic Effects?
Authors: Nil Hocaoglu
Sule Kalkan
Mujgan Buyukdeligoz
Kubilay Oransay
Yesim Tuncok
Publication date: 01-06-2012
Publisher: Humana Press Inc
Published in: Cardiovascular Toxicology / Issue 2/2012
Print ISSN: 1530-7905
Electronic ISSN: 1559-0259
DOI: https://doi.org/10.1007/s12012-011-9147-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Is Serum S100B Protein a Biomarker for Amitriptyline-Induced Cardiovascular Toxic Effects?

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2012

High-Sensitivity CRP in Opiate Addiction: Relative and Age-Dependent Elevations

Leflunomide-Induced Pulmonary Hypertension in a Young Woman with Rheumatoid Arthritis: A Case Report

NAD(P)H: Quinone Oxidoreductase 1 is Induced by Progesterone in Cardiomyocytes

Timely Recognition of Cardiovascular Toxicity by Anticancer Agents: A Common Objective of the Pharmacologist, Oncologist and Cardiologist

Molecular Analysis of Mitochondrial Compromise in Rodent Cardiomyocytes Exposed Long Term to Nucleoside Reverse Transcriptase Inhibitors (NRTIs)

Toxic Effects of Marijuana on the Cardiovascular System